F32.0 F32.1 F33.0 F33.1
Conditions
Interventions
Group 1: Intervention group with immediate access to "Invirto - Die Therapie gegen Depression" (an app-based intervention for patients with depression)
Group 2: Care as usual control group: care as us
Sponsors
Sympatient GmbH
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ? Informed written consent to participate in the study ? PHQ-9 score of = 5 (Kroenke et al., 2001) ? Presence of a smartphone with internet access
Exclusion criteria
Exclusion criteria: ? Acute suicidal intentions ? Diagnosis of schizophrenic or bipolar disorder ? Diagnosis of a severe depressive disorder ? Contraindications for the use of Invirto - Die Therapie gegen Depression according to the instructions for use ? Change in medication for the treatment of depressive symptoms in the last four weeks ? Current participation in another intervention study in the field of psychotherapy ? Currently undergoing psychotherapeutic treatment at the start of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is depressive symptoms after three months in the intervention group compared to the control group, taking into account the initial symptoms at Baseline. Depressive symptoms are recorded using the Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Depressive symptoms as rated by clinicans, Quick Inventory of Depressive Symptomatology (QIDS-C16; Rush et al., 2003) - Depression-related health literacy, Depression Literacy Scale (D-Lit; Freitag et al., 2018; Griffiths et al., 2004) | — |
Countries
Germany
Contacts
Public ContactLena Jelinek
Universitätsklinikum Hamburg-Eppendorf
Outcome results
None listed